HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossing, P. Articles by Parving, H.-H. Search for Related Content PubMed PubMed Citation Articles by Rossing, P. Articles by Parving, H.-H. Social Bookmarking                What's this?

Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy

¹ Steno Diabetes Center, Gentofte, Denmark
² Faculty of Health Science, University of Aarhus, Aarhus, Denmark

Address correspondence and reprint requests to Peter Rossing, MD, DMSC, Niels Steensens Vej 2, DK 2820, Gentofte, Denmark. E-mail: pro{at}steno.dk

OBJECTIVE—The purpose of this study was to assess agreement between glomerular filtration rate (GFR) and the decline in GFR estimated with the Modification of Diet in Renal Disease (MDRD) Study Group equation or the Cockcroft-Gault formula and measured by the plasma clearance of ⁵¹Cr-EDTA.

RESEARCH DESIGN AND METHODS—We followed a cohort of 156 microalbuminuric type 2 diabetic patients for 8 years with four measurements of GFR and another cohort of 227 type 2 diabetic patients with overt diabetic nephropathy for 6.5 (range 3–17) years with seven (3–22) measurements of GFR.

RESULTS—For patients with microalbuminuria, mean ± SD baseline GFR was 117 ± 24 measured, 92 ± 20 estimated (MDRD equation), or 103 ± 24 ml · min^–1 per 1.73 m² estimated (Cockcroft-Gault formula) (both P < 0.001); 95% limits of agreement were –66.1 to 20.3 (MDRD equation) and –58.7 to 30.7 (Cockcroft-Gault formula). The rate of decline in GFR was 4.1 ± 4.2 measured, 2.9 ± 2.8 estimated (MDRD equation), or 3.4 ± 3.2 ml · min^–1 per 1.73 m² estimated (Cockcroft-Gault formula) (both P < 0.001). For patients with overt nephropathy, baseline GFR was 84 ± 30 measured, 73 ± 24 estimated (MDRD equation), or 81 ± 28 ml · min^–1 per 1.73 m² estimated (Cockcroft-Gault formula) (both P < 0.001) with 95% limits of agreement –47 to 25 (MDRD equation) and –39 to 33 (Cockcroft-Gault formula). The rate of decline in GFR was 5.2 ± 4.1 measured, 4.2 ± 3.8 estimated (MDRD equation), and 4.6 ± 4.1 ml · min^–1 per 1.73 m² estimated (Cockcroft-Gault formula) (both P < 0.001).

CONCLUSIONS—Particularly in microalbuminuric (hyperfiltering) patients, GFR is significantly underestimated with wide limits of agreement by the MDRD equation as well as by the Cockcroft-Gault formula. The rate of decline in GFR is also significantly underestimated with both equations. This makes GFR estimations based upon these equations unacceptable for monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.

Abbreviations: BSA, body surface area • GFR, glomerular filtration rate • MDRD, Modification of Diet in Renal Disease

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Xie, M. M. Joffe, S. M. Brunelli, G. Beck, G. M. Chertow, J. C. Fink, T. Greene, C.-y. Hsu, J. W. Kusek, R. Landis, et al. A Comparison of Change in Measured and Estimated Glomerular Filtration Rate in Patients with Nondiabetic Kidney Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1332 - 1338. [Abstract] [Full Text] [PDF]

				P. Farbom, B. Wahlstrand, P. Almgren, S. Skrtic, J. Lanke, L. Weiss, S. Kjeldsen, T. Hedner, and O. Melander Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension: The Nordic Diltiazem Study Hypertension, July 1, 2008; 52(1): 115 - 122. [Abstract] [Full Text] [PDF]

				T. Ledson, M. L. P. Howse, N. B. Roberts, G. J. Kemp, and P. S. Williams Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria NDT Plus, June 1, 2008; 1(3): 194 - 195. [Full Text] [PDF]

				E. Premaratne, R. J. MacIsaac, S. Finch, S. Panagiotopoulos, E. Ekinci, and G. Jerums Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 Diabetes Diabetes Care, May 1, 2008; 31(5): 971 - 973. [Abstract] [Full Text] [PDF]

				C. A. Schneider, E. Ferrannini, R. DeFronzo, G. Schernthaner, J. Yates, and E. Erdmann Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease J. Am. Soc. Nephrol., January 1, 2008; 19(1): 182 - 187. [Abstract] [Full Text] [PDF]

				V. Rigalleau, M.-C. Beauvieux, C. Lasseur, P. Chauveau, C. Raffaitin, C. Perlemoine, N. Barthe, C. Combe, and H. Gin The Combination of Cystatin C and Serum Creatinine Improves the Monitoring of Kidney Function in Patients with Diabetes and Chronic Kidney Disease Clin. Chem., November 1, 2007; 53(11): 1988 - 1989. [Full Text] [PDF]

				M. S. MacGregor How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix8 - ix18. [Full Text] [PDF]

				E. J. Lamb, D. G. Fogarty, P. Murchie, E. Ritz, C. Isles, A. Jardine, D. Goldsmith, M. Cassidy, D. O'Donoghue, N. McIntyre, et al. Speaker Abstracts: Tuesday, 6 February 2007 Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix45 - ix53. [Full Text] [PDF]

				V. Rigalleau, C. Lasseur, C. Raffaitin, M.-C. Beauvieux, N. Barthe, P. Chauveau, C. Combe, and H. Gin Normoalbuminuric Renal-Insufficient Diabetic Patients: A lower-risk group Diabetes Care, August 1, 2007; 30(8): 2034 - 2039. [Abstract] [Full Text] [PDF]

				M.-C. Beauvieux, F. Le Moigne, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, H. Gin, and V. Rigalleau New Predictive Equations Improve Monitoring of Kidney Function in Patients With Diabetes Diabetes Care, August 1, 2007; 30(8): 1988 - 1994. [Abstract] [Full Text] [PDF]

				V. Rigalleau, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, and H. Gin The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects Nephrol. Dial. Transplant., March 1, 2007; 22(3): 813 - 818. [Abstract] [Full Text] [PDF]

				N. Fontsere, J. Bonal, and R. Romero Reply Nephrol. Dial. Transplant., March 1, 2007; 22(3): 960 - 960. [Full Text] [PDF]

				V. Rigalleau, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, and H. Gin Prediction of glomerular filtration rate decline in diabetic subjects with impaired renal function Nephrol. Dial. Transplant., March 1, 2007; 22(3): 959 - 960. [Full Text] [PDF]

				R. A. Chudleigh, G. Dunseath, W. Evans, J. N. Harvey, P. Evans, R. Ollerton, and D. R. Owens How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes? Diabetes Care, February 1, 2007; 30(2): 300 - 305. [Abstract] [Full Text] [PDF]

				M. Tonelli, F. Sacks, M. Pfeffer, Z.H. Gao, G. Curhan, for the Cholesterol and Recurrent Events (CARE) Tr, P. Rossing, K. Rossing, P. Gaede, O. Pedersen, et al. Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients: Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005 J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2077 - 2085. [Full Text] [PDF]